Your browser doesn't support javascript.
loading
XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells.
Wahida, Adam; Müller, Madeleine; Hiergeist, Andreas; Popper, Bastian; Steiger, Katja; Branca, Caterina; Tschurtschenthaler, Markus; Engleitner, Thomas; Donakonda, Sainitin; De Coninck, Jordy; Öllinger, Rupert; Pfautsch, Marie K; Müller, Nicole; Silva, Miguel; Usluer, Sinem; Thiele Orberg, Erik; Böttcher, Jan P; Pfarr, Nicole; Anton, Martina; Slotta-Huspenina, Julia B; Nerlich, Andreas G; Madl, Tobias; Basic, Marijana; Bleich, André; Berx, Geert; Ruland, Jürgen; Knolle, Percy A; Rad, Roland; Adolph, Timon E; Vandenabeele, Peter; Kanegane, Hirokazu; Gessner, André; Jost, Philipp J; Yabal, Monica.
Affiliation
  • Wahida A; Medical Department III for Hematology and Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Müller M; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • Hiergeist A; Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Popper B; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Steiger K; Biomedical Center, Core Facility Animal Models, Ludwig-Maximilians-University, Planegg-Martinsried, Germany.
  • Branca C; Institute of Pathology and Pathological Anatomy, Technical University of Munich, Munich, Germany.
  • Tschurtschenthaler M; Comparative Experimental Pathology and Digital Pathology, Institute for Pathology and Pathological Anatomy, Technical University of Munich, Munich, Germany.
  • Engleitner T; Medical Department III for Hematology and Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Donakonda S; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • De Coninck J; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • Öllinger R; Institute of Translational Cancer Research and Experimental Cancer Therapy, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Pfautsch MK; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • Müller N; Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Silva M; Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Usluer S; German Center for Infection Research (DZIF), Munich, Germany.
  • Thiele Orberg E; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Böttcher JP; Cancer Research Institute Ghent, Ghent, Belgium.
  • Pfarr N; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • Anton M; Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Slotta-Huspenina JB; Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Nerlich AG; Medical Department III for Hematology and Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Madl T; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • Basic M; Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Bleich A; Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Graz, Austria.
  • Berx G; BioTechMed Graz, Graz, Austria.
  • Ruland J; Medical Department III for Hematology and Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Knolle PA; TranslaTUM, Center for Translational Cancer Research, Munich, Germany.
  • Rad R; Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Adolph TE; Institute of Pathology and Pathological Anatomy, Technical University of Munich, Munich, Germany.
  • Vandenabeele P; Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Kanegane H; Institute of Pathology and Pathological Anatomy, Technical University of Munich, Munich, Germany.
  • Gessner A; Institute of Pathology, Academic Clinic Munich-Bogenhausen, Munich, Germany.
  • Jost PJ; Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Graz, Austria.
  • Yabal M; BioTechMed Graz, Graz, Austria.
Sci Immunol ; 6(65): eabf7235, 2021 Nov 05.
Article in En | MEDLINE | ID: mdl-34739338
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Tumor Necrosis Factor, Type I / Receptors, Tumor Necrosis Factor, Type II / X-Linked Inhibitor of Apoptosis Protein / Toll-Like Receptor 5 / Inflammation / Intestines Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Sci Immunol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Tumor Necrosis Factor, Type I / Receptors, Tumor Necrosis Factor, Type II / X-Linked Inhibitor of Apoptosis Protein / Toll-Like Receptor 5 / Inflammation / Intestines Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Sci Immunol Year: 2021 Document type: Article Affiliation country: Country of publication: